M&A TRANSACTION · 2019
BTG PLC acquired by Boston Scientific Corporation
$3.62B· 13.7x EBITDA· 4.00x revenue
Target
BTG PLC
Acquirer
Boston Scientific Corporation
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$914.1M
EBITDA
$264.2M
Deal Value
$3.62B
EV/EBITDA
13.7x
Context
This $3.62B acquisition of BTG PLC by Boston Scientific Corporation sits in the medical devices sub-vertical. The 13.7x EBITDA multiple paid in 2019 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Boston Scientific Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from SEC filings and financial statements. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the BTG PLC acquisition.